A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Status:
Recruiting

Trial end date:
2022-02-23

Target enrollment:

Participant gender:

This is a randomised, placebo-controlled study of the safety and tolerability of single doses of MEDI0618 in healthy volunteer subjects.

Phase 1

AstraZeneca